Jones Financial Companies
VERA icon

Jones Financial Companies’s Vera Therapeutics VERA Stock Holding History

Jones Financial Companies’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.67K Buy
110
+6
+6% +$224 ﹤0.01% 4120
2026
Q1 		$4.04K Hold
104
– – ﹤0.01% 3924
2025
Q4 		$5.27K Hold
104
– – ﹤0.01% 3475
2025
Q3 		$2.93K Hold
104
– – ﹤0.01% 3567
2025
Q2 		$2.36K Buy
104
+100
+2,500% +$2.25K ﹤0.01% 3412
2025
Q1 		$107 Buy
+4
New +$129 ﹤0.01% 3623

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jones Financial Companies's VERA Position: Q2 2026 in Review

Jones Financial Companies increased its Vera Therapeutics (VERA) stake by 5.8% in Q2 2026, buying an estimated $224 and bringing the position to 110 shares worth $4.67K. The position accounts for ﹤0.01% of the portfolio, ranked #4120.

Jones Financial Companies first reported a position in VERA in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.27K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Jones Financial Companies held 110 shares of Vera Therapeutics worth $4.67K as of Q2 2026.
  • Jones Financial Companies bought 6 Vera Therapeutics shares in Q2 2026, an estimated $224.
  • Vera Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4120 holding.
  • Jones Financial Companies first reported a position in Vera Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's Vera Therapeutics position peaked at $5.27K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.